PMV Pharmaceuticals Inc (PMVP)
1.64
+0.01
(+0.61%)
USD |
NASDAQ |
Nov 04, 16:00
PMV Pharmaceuticals Price to Book Value: 0.3942 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.3942 |
| November 01, 2024 | 0.3918 |
| October 31, 2024 | 0.3918 |
| October 30, 2024 | 0.3822 |
| October 29, 2024 | 0.3966 |
| October 28, 2024 | 0.3991 |
| October 25, 2024 | 0.3991 |
| October 24, 2024 | 0.3991 |
| October 23, 2024 | 0.3846 |
| October 22, 2024 | 0.4111 |
| October 21, 2024 | 0.3822 |
| October 18, 2024 | 0.3798 |
| October 17, 2024 | 0.3846 |
| October 16, 2024 | 0.3846 |
| October 15, 2024 | 0.3582 |
| October 14, 2024 | 0.3606 |
| October 11, 2024 | 0.3582 |
| October 10, 2024 | 0.363 |
| October 09, 2024 | 0.3582 |
| October 08, 2024 | 0.357 |
| October 07, 2024 | 0.3606 |
| October 04, 2024 | 0.3678 |
| October 03, 2024 | 0.3558 |
| October 02, 2024 | 0.3582 |
| October 01, 2024 | 0.3606 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.3582 |
| September 27, 2024 | 0.3606 |
| September 26, 2024 | 0.357 |
| September 25, 2024 | 0.3582 |
| September 24, 2024 | 0.3582 |
| September 23, 2024 | 0.3582 |
| September 20, 2024 | 0.3606 |
| September 19, 2024 | 0.3654 |
| September 18, 2024 | 0.363 |
| September 17, 2024 | 0.3606 |
| September 16, 2024 | 0.3606 |
| September 13, 2024 | 0.363 |
| September 12, 2024 | 0.3582 |
| September 11, 2024 | 0.363 |
| September 10, 2024 | 0.3582 |
| September 09, 2024 | 0.3654 |
| September 06, 2024 | 0.3606 |
| September 05, 2024 | 0.3678 |
| September 04, 2024 | 0.363 |
| September 03, 2024 | 0.3798 |
| August 30, 2024 | 0.3774 |
| August 29, 2024 | 0.3846 |
| August 28, 2024 | 0.3822 |
| August 27, 2024 | 0.3798 |
| August 26, 2024 | 0.3846 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2648
Minimum
Oct 25 2023
11.05
Maximum
Sep 29 2020
2.261
Average
1.959
Median
Price to Book Value Benchmarks
| Marker Therapeutics Inc | 3.237 |
| CEL-SCI Corp | 5.944 |
| AIM ImmunoTech Inc | 2.666 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 1.64 |
| Earnings Yield | -59.15% |
| Market Cap | 84.49M |